Production (Stage)
Disc Medicine, Inc.
IRON
$53.71
$1.001.90%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -15.71% | -10.74% | -0.94% | 2.22% | -14.29% |
| Total Depreciation and Amortization | 122.22% | -18.18% | -90.00% | 323.08% | 4.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 75.73% | 30.10% | -49.99% | -13.17% | 682.12% |
| Change in Net Operating Assets | -2,205.42% | -106.73% | 2.79% | 166.22% | -308.31% |
| Cash from Operations | -50.06% | -58.82% | -12.79% | 54.19% | -88.80% |
| Capital Expenditure | -89.53% | -5,712.50% | 166.67% | 104.48% | -2,133.33% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -27,718.01% | 98.63% | 67.65% | -- | -- |
| Cash from Investing | -19,018.72% | 97.99% | 67.65% | -327,883.58% | -2,133.33% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 19,439.52% | 182.16% | -99.75% | 989.25% | 104.95% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 773.80% | -- | -- | -- | -- |
| Cash from Financing | 748.18% | 6,659.86% | -99.75% | 989.25% | 104.95% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -34,433.66% | 99.77% | -42.09% | -248.71% | -76.93% |